These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 10809812
1. A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Oka K, Imai E, Moriyama T, Akagi Y, Ando A, Hori M, Okuyama A, Toki K, Kyo M, Kokado Y, Takahara S. Nephrol Dial Transplant; 2000 May; 15(5):689-95. PubMed ID: 10809812 [Abstract] [Full Text] [Related]
2. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril. Jeong HJ, Kim YS, Kwon KW, Kim MS, Kim S, Choi KH, Lee HY, Han DS, Park K. Clin Transplant; 2003 Apr; 17(2):108-13. PubMed ID: 12709075 [Abstract] [Full Text] [Related]
3. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors]. Shi X, Chen X, Liu S, Zhuang Y, Zhang Y. Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603 [Abstract] [Full Text] [Related]
4. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation. Namba Y, Oka K, Moriyama T, Ichimaru N, Kyo M, Kokado Y, Ito T, Imai E, Aozasa K, Okuyama A, Takahara S. Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321 [Abstract] [Full Text] [Related]
5. Utility of Oxford Classification in Post-Transplant Immunoglobulin A Nephropathy. Agrawal V, Singh A, Kaul A, Verma R, Jain M, Pandey R. Transplant Proc; 2017 Dec; 49(10):2274-2279. PubMed ID: 29198660 [Abstract] [Full Text] [Related]
6. Glomerular C4d in Post-Transplant IgA Nephropathy is associated with decreased allograft survival. Eder M, Kozakowski N, Omic H, Aigner C, Kläger J, Perschl B, Reindl-Schwaighofer R, Bond G, Böhmig GA, Kikić Ž. J Nephrol; 2021 Jun; 34(3):839-849. PubMed ID: 33306182 [Abstract] [Full Text] [Related]
7. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy. Park S, Baek CH, Cho H, Yu MY, Kim YC, Go H, Kim YH, Lee JP, Min SI, Ha J, Moon KC, Kim YS, Ahn C, Park SK, Lee H. Am J Transplant; 2019 Jan; 19(1):145-155. PubMed ID: 29718591 [Abstract] [Full Text] [Related]
8. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT. Lemes-Canuto AP, de Sandes-Freitas TV, Medina-Pestana JO, Mastroianni-Kirsztajn G. J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382 [Abstract] [Full Text] [Related]
9. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, Wang M, Peng Y. BMC Nephrol; 2020 Jul 01; 21(1):247. PubMed ID: 32611399 [Abstract] [Full Text] [Related]
10. Predicting Post-Transplant Recurrence of IgA Nephropathy: The Importance of Crescents. Avasare RS, Rosenstiel PE, Zaky ZS, Tsapepas DS, Appel GB, Markowitz GS, Bomback AS, Canetta PA. Am J Nephrol; 2017 Jul 01; 45(2):99-106. PubMed ID: 28056461 [Abstract] [Full Text] [Related]
11. Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. Kanno Y, Okada H, Yamaji Y, Nakazato Y, Suzuki H. QJM; 2005 Mar 01; 98(3):199-203. PubMed ID: 15728401 [Abstract] [Full Text] [Related]
12. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection. Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M. BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274 [Abstract] [Full Text] [Related]
13. Recurrence of crescentic IgA nephropathy after renal transplantation. Zagkotsis G, Vourlakou C, Paraskevopoulos A, Apostolou T. CEN Case Rep; 2018 Nov 14; 7(2):268-273. PubMed ID: 29802527 [Abstract] [Full Text] [Related]
14. The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification. Kamiyama T, Moriyama T, Kumon S, Karasawa K, Nitta K. Clin Exp Nephrol; 2019 Jun 14; 23(6):834-840. PubMed ID: 30796546 [Abstract] [Full Text] [Related]
15. Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft. Tsuchiya T, Ito S, Yamaguchi Y, Moriyama Y, Ehara H, Deguchi T. Clin Nephrol; 2010 Jan 14; 73(1):68-71. PubMed ID: 20040355 [Abstract] [Full Text] [Related]
16. Outcomes of IgA Nephropathy with Segmental Glomerular Necrosis But without Crescent Formation. Tan M, Li W, Zou G, Zhang C, Fang J. Am J Nephrol; 2016 Jan 14; 43(5):341-7. PubMed ID: 27166147 [Abstract] [Full Text] [Related]
17. [A clinicopathological study of recurrent IgA nephropathy following renal transplantation]. Matsugami K, Naito T, Nitta K, Nihei H, Tanabe K, Toma H, Yamaguchi Y. Nihon Jinzo Gakkai Shi; 1998 Jul 14; 40(5):322-8. PubMed ID: 9752688 [Abstract] [Full Text] [Related]
18. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G. J Nephrol; 2012 Jul 14; 25(5):810-8. PubMed ID: 22252844 [Abstract] [Full Text] [Related]
19. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy. Jeong HJ, Park SK, Cho YM, Kim MS, Kim YS, Choi J, Kim SI, Lim BJ. Hum Pathol; 2008 Oct 14; 39(10):1511-8. PubMed ID: 18620732 [Abstract] [Full Text] [Related]
20. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Nephrol Dial Transplant; 2009 Dec 14; 24(12):3694-701. PubMed ID: 19628647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]